71 /100
HIGH RISK
Score updated May 30, 2026

SCNI — Scinai Immunotherapeutics Ltd. Dilution Risk Tracker

Track SCNI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SCNI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
40
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
60%
🔄 Reverse Split 65%
• 50-day avg $0.58 below $1 exchange minimum
• 6 months cash with weak price
📜 Warrant Exercise 60%
• Massive warrant overhang: 41% of shares outstanding
• Warrant risk score very high (90/100)
📉 Score Deterioration 50%
• Score rose 47 points recently (worsening)
• Score in HIGH risk zone (71/100)
🔔 Track SCNI — Get forecast alerts →

💹 Market Data

Market Cap$1.78M
Shares Outstanding3.96M
FloatN/A
Cash$1.66M
Debt$2.27M
Short InterestN/A

🏛 Institutional Holdings

7 institutional holders · 81.9K shares
#1 Citadel Advisors Llc 34.6K shares
#2 Xtx Topco Ltd 27.3K shares
#3 Virtu Financial LLC 15.4K shares
+ 4 more holders Sign up free to view →

📉 Short Interest

Short Interest157.8K
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track SCNI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SCNI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for SCNI
📊 SCNI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SCNI Signal Convergence & Dark Pool Activity — StonkWhisper 📄 SCNI Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.